Organigram Global (OGI) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Organigram Global (OGI) has outperformed Stablecoin Development (SDEV) over the past year, losing 51.0% versus a loss of 66.8%. Over five years, OGI leads with a -89.4% price change compared with -99.9% for SDEV. Organigram Global is the larger company by market cap ($137.1 million vs $103.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OGI | SDEV |
|---|---|---|
| Share price | $0.9511 | $1.99 |
| Market cap | $137.10M | $102.99M |
| 1-day change | -0.93% | -28.42% |
| YTD return | -43.39% | -92.94% |
| 1-year return | -50.97% | -66.83% |
| 5-year return | -89.39% | -99.94% |
| P/E ratio (TTM) | 2.21 | — |
| Forward P/E | 39.63 | — |
| EPS (TTM) | $0.43 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.24 | $99.75 |
| 52-week low | $0.853 | $0.78 |
| Distance from 52-week high | -57.54% | -98.01% |
| Analyst consensus | buy | — |
| Average volume | 884.72K | 11.74M |
| Shares outstanding | 144.15M | 51.75M |
| Employees | 1,139 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OGI has outperformed SDEV by 15.9 percentage points over the past year.
About Organigram Global
OGI stock →Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,139 employees
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
OGI vs SDEV FAQ
Which is bigger, Organigram Global or Stablecoin Development?
Organigram Global (OGI) is larger, with a market capitalization of $137.10M compared with $102.99M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, OGI or SDEV?
OGI returned -50.97% over the past 12 months, compared with -66.83% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Organigram Global and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.